Opinion/decision on a Paediatric investigation plan (PIP): Benlysta, belimumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Musculoskeletal and connective tissue diso

Submitted by Anonymous (not verified) on 11 June 2025 - 13:34

Opinion/decision on a Paediatric investigation plan (PIP): Benlysta, belimumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0109/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More